ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p117.xml Myeloid Growth Factor Guidelines: Moving Toward a Societal Perspective 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p118.xml Multiple Myeloma Guidelines 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p149.xml The Emerging Role of Novel Therapies for the Treatment of Relapsed Myeloma 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p163.xml Role of Bone Marrow Transplantation in the Disease Pathway of Myeloma 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p170.xml Multiple Myeloma: Most Common End-Organ Damage and Management 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p179.xml Managing Systemic Light-Chain Amyloidosis 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p188.xml Myeloid Growth Factors Guidelines 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p203.xml Growth Factors in Leukemia 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p217.xml Summary and Comparison of Myeloid Growth Factor Guidelines in Patients Receiving Cancer Chemotherapy 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p229.xml Myeloid Growth Factor Therapy for Prophylaxis of Febrile Neutropenia in Non-Myeloid Malignancies: Appropriate Doses and Schedules 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/5/2/article-p235.xml Antibacterial Prophylaxis in Patients with Neutropenia 2019-01-04